113 related articles for article (PubMed ID: 38423670)
1. Apoptotic Potential and Molecular Docking of 3,4-Dihydro-lactucin, a Compound With Anticancer Properties Derived from
Taechowisan T; Chuen-Im T; Phutdhawong WS
Anticancer Res; 2024 Mar; 44(3):1161-1171. PubMed ID: 38423670
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial and Anticancer Properties of
Taechowisan T; Chuen-Im T; Phutdhawong WS
Pak J Biol Sci; 2022 Sep; 25(10):922-928. PubMed ID: 36404746
[TBL] [Abstract][Full Text] [Related]
3. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
Sever B; Altıntop MD; Çiftçi GA; Özdemir A
Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
[TBL] [Abstract][Full Text] [Related]
4. Dehydroleucodine inhibits tumor growth in a preclinical melanoma model by inducing cell cycle arrest, senescence and apoptosis.
Costantino VV; Lobos-Gonzalez L; Ibañez J; Fernandez D; Cuello-Carrión FD; Valenzuela MA; Barbieri MA; Semino SN; Jahn GA; Quest AF; Lopez LA
Cancer Lett; 2016 Mar; 372(1):10-23. PubMed ID: 26718258
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity and molecular docking analysis of racemolactone I, a new sesquiterpene lactone isolated from
Alam P; Tyagi R; Farah MA; Rehman MT; Hussain A; AlAjmi MF; Siddiqui NA; Al-Anazi KM; Amin S; Mujeeb M; Mir SR
Pharm Biol; 2021 Dec; 59(1):941-952. PubMed ID: 35294328
[TBL] [Abstract][Full Text] [Related]
6. Dehydrocostus lactone inhibits cell proliferation and induces apoptosis by PI3K/Akt/Bad and ERS signalling pathway in human laryngeal carcinoma.
Zhang R; Hao J; Wu Q; Guo K; Wang C; Zhang WK; Liu W; Wang Q; Yang X
J Cell Mol Med; 2020 Jun; 24(11):6028-6042. PubMed ID: 32319208
[TBL] [Abstract][Full Text] [Related]
7. Cycloartobiloxanthone Induces Human Lung Cancer Cell Apoptosis
Losuwannarak N; Sritularak B; Chanvorachote P
In Vivo; 2018; 32(1):71-78. PubMed ID: 29275301
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative, apoptosis-inducing activity and molecular docking studies of sydnones compounds.
Hossain SL; Mathews M; Bhyranalyar Nagarajappa VS; Kumar BK; Veerappa Yelamaggad CV; Singh CR
J Cancer Res Ther; 2022; 18(3):681-690. PubMed ID: 34708812
[TBL] [Abstract][Full Text] [Related]
9. Anticancer potential of Phoenix dactylifera L. seed extract in human cancer cells and pro-apoptotic effects mediated through caspase-3 dependent pathway in human breast cancer MDA-MB-231 cells: an in vitro and in silico investigation.
Khan MA; Singh R; Siddiqui S; Ahmad I; Ahmad R; Upadhyay S; Barkat MA; Ali AMA; Zia Q; Srivastava A; Trivedi A; Husain I; Srivastava AN; Mishra DP
BMC Complement Med Ther; 2022 Mar; 22(1):68. PubMed ID: 35291987
[TBL] [Abstract][Full Text] [Related]
10. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Evaluation of a New Series of Arylidene Indanones as Potential Anticancer Agents.
Özdemir A; Gökbulut S; Sever B; Çiftçi GA; Altıntop MD
Anticancer Agents Med Chem; 2018; 18(10):1394-1404. PubMed ID: 29210665
[TBL] [Abstract][Full Text] [Related]
12. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.
Hajipour F; Mahdavinia M; Fereidoonnezhad M
Anticancer Agents Med Chem; 2022; 22(6):1149-1158. PubMed ID: 34259151
[TBL] [Abstract][Full Text] [Related]
13. Binding and molecular dynamic studies of sesquiterpenes (2R-acetoxymethyl-1,3,3-trimethyl-4t-(3-methyl-2-buten-1-yl)-1t-cyclohexanol) derived from marine Streptomyces sp. VITJS8 as potential anticancer agent.
Naine SJ; Devi CS; Mohanasrinivasan V; Doss CG; Kumar DT
Appl Microbiol Biotechnol; 2016 Mar; 100(6):2869-82. PubMed ID: 26590587
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of apoptosis induction by Gaillardin, a sesquiterpene lactone, in breast cancer cell lines : Gaillardin-induced apoptosis in breast cancer cell lines.
Fallahian F; Aghaei M; Abdolmohammadi MH; Hamzeloo-Moghadam M
Cell Biol Toxicol; 2015 Dec; 31(6):295-305. PubMed ID: 26843455
[TBL] [Abstract][Full Text] [Related]
15. In silico and in vitro analysis of coumarin derivative induced anticancer effects by undergoing intrinsic pathway mediated apoptosis in human stomach cancer.
Perumalsamy H; Sankarapandian K; Veerappan K; Natarajan S; Kandaswamy N; Thangavelu L; Balusamy SR
Phytomedicine; 2018 Jul; 46():119-130. PubMed ID: 30097112
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative and Pro-Apoptotic Effects of Thiazolo[3,2-b][1,2,4]triazoles in Breast and Cervical Cancer Cells.
Khan I; Zaib S; Javed M; Rashid F; Iqbal J; Ibrar A
Anticancer Agents Med Chem; 2021 Oct; 21(16):2181-2191. PubMed ID: 33573578
[TBL] [Abstract][Full Text] [Related]
17. Centaurea cyanus extracted 13-O-acetylsolstitialin A decrease Bax/Bcl-2 ratio and expression of cyclin D1/Cdk-4 to induce apoptosis and cell cycle arrest in MCF-7 and MDA-MB-231 breast cancer cell lines.
Keyvanloo Shahrestanaki M; Bagheri M; Ghanadian M; Aghaei M; Jafari SM
J Cell Biochem; 2019 Oct; 120(10):18309-18319. PubMed ID: 31161672
[TBL] [Abstract][Full Text] [Related]
18. Androstane derivatives induce apoptotic death in MDA-MB-231 breast cancer cells.
Jakimov DS; Kojić VV; Aleksić LD; Bogdanović GM; Ajduković JJ; Djurendić EA; Penov Gaši KM; Sakač MN; Jovanović-Šanta SS
Bioorg Med Chem; 2015 Nov; 23(22):7189-98. PubMed ID: 26494582
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, evaluation of new 3-acetylisoxazolines and their hybrid analogous as anticancer agents: In vitro and in silico analysis.
Fawzi M; Oubella A; Bimoussa A; Bamou FZ; Khdar ZA; Auhmani A; Riahi A; Robert A; Morjani H; Itto MYA
Comput Biol Chem; 2022 Jun; 98():107666. PubMed ID: 35381466
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer.
Rajagopalan P; Alahmari KA; Elbessoumy AA; Balasubramaniam M; Suresh R; Shariff ME; Chandramoorthy HC
Cancer Chemother Pharmacol; 2016 Feb; 77(2):393-404. PubMed ID: 26781309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
